Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies
With the development of anti-tumor drugs, tyrosine kinase inhibitors (TKIs) are an indispensable part of targeted therapy. They can be superior to traditional chemotherapeutic drugs in selectivity, safety, and efficacy. However, they have been found to be associated with serious adverse effects in u...
Enregistré dans:
Auteurs principaux: | Mengfei Cheng, Fang Yang, Jiahui Liu, Dan Yang, Shuo Zhang, Yang Yu, Shuai Jiang, Mei Dong |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/55ad76f9d3e0435eaee247780c1c1fba |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Risk of QTc Prolongation in Non-Diabetic and Diabetic Patients Taking Tyrosine Kinase Inhibitors (TKIs)- A Patient Safety Project at a Private Oncology Practice
par: Zhongju Lu, et autres
Publié: (2021) -
The effect of oral ondansetron on QT interval in children with acute gastroenteritis; a retrospective observational study
par: Heewon Yang, et autres
Publié: (2021) -
QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
par: Erande S, et autres
Publié: (2019) -
The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?
par: Agnieszka Kaczmarska, et autres
Publié: (2021) - Journal of atrial fibrillation